More about
Emory University
News
June 15, 2020
2 min read
Save
Belantamab mafodotin: A ‘big step forward’ in relapsed, refractory multiple myeloma
News
June 12, 2020
5 min read
Save
Low-dose radiation after transoral resection effective in HPV-related oropharynx cancer
News
June 12, 2020
4 min read
Save
An ‘urgent need’: Steps to increase black participation in diabetes clinical trials
News
June 04, 2020
4 min read
Save
Nivolumab plus ipilimumab confers sustained survival benefit in advanced NSCLC
News
April 19, 2020
2 min read
Save
Physicians receive awards for service to patients near end of life
News
April 14, 2020
2 min read
Save
Experts: HHS plan to optimize ventilators is ‘suboptimal’
News
February 20, 2020
11 min read
Save
Push to end HIV epidemic in US complicated by ‘brain drain’
News
January 08, 2020
5 min read
Save
In-office testing, off-label therapy may be best approach for EKC
News
December 27, 2019
3 min read
Save
Anti-BCMA immunoconjugate appears effective for multiple myeloma

Belantamab mafodotin, an investigational anti-B-cell maturation antigen monoclonal antibody-drug conjugate, demonstrated clinically meaningful response rates among patients with heavily pretreated multiple myeloma, according to results of the randomized phase 2 DREAMM-2 trial published in Lancet Oncology.
News
December 27, 2019
4 min read
Save